Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

833 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comprehensive genomic profiling by liquid biopsy captures tumor heterogeneity and identifies cancer vulnerabilities in patients with RAS/BRAFV600E wild-type metastatic colorectal cancer in the CAPRI 2-GOIM trial.
Ciardiello D, Boscolo Bielo L, Napolitano S, Martinelli E, Troiani T, Nicastro A, Latiano TP, Parente P, Maiello E, Avallone A, Normanno N, Pisconti S, Nisi C, Bordonaro R, Russo AE, Tamburini E, Toma I, Lotesoriere C, Vallarelli S, Zampino MG, Fazio N, Curigliano G, De Vita F, Ciardiello F, Martini G; CAPRI-2 GOIM study group. Ciardiello D, et al. Among authors: curigliano g. Ann Oncol. 2024 Dec;35(12):1105-1115. doi: 10.1016/j.annonc.2024.08.2334. Epub 2024 Aug 29. Ann Oncol. 2024. PMID: 39214459
Cancer survivorship at heart: a multidisciplinary cardio-oncology roadmap for healthcare professionals.
Bisceglia I, Canale ML, Silvestris N, Gallucci G, Camerini A, Inno A, Camilli M, Turazza FM, Russo G, Paccone A, Mistrulli R, De Luca L, Di Fusco SA, Tarantini L, Lucà F, Oliva S, Moreo A, Maurea N, Quagliariello V, Ricciardi GR, Lestuzzi C, Fiscella D, Parrini I, Racanelli V, Russo A, Incorvaia L, Calabrò F, Curigliano G, Cinieri S, Gulizia MM, Gabrielli D, Oliva F, Colivicchi F. Bisceglia I, et al. Among authors: curigliano g. Front Cardiovasc Med. 2023 Sep 15;10:1223660. doi: 10.3389/fcvm.2023.1223660. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37786510 Free PMC article. Review.
Corrigendum: Cancer survivorship at heart: a multidisciplinary cardio-oncology roadmap for healthcare professionals.
Bisceglia I, Canale ML, Silvestris N, Gallucci G, Camerini A, Inno A, Camilli M, Turazza FM, Russo G, Paccone A, Mistrulli R, De Luca L, Di Fusco SA, Tarantini L, Lucà F, Oliva S, Moreo A, Maurea N, Quagliariello V, Ricciardi GR, Lestuzzi C, Fiscella D, Parrini I, Racanelli V, Russo A, Incorvaia L, Calabrò F, Curigliano G, Cinieri S, Gulizia MM, Gabrielli D, Oliva F, Colivicchi F. Bisceglia I, et al. Among authors: curigliano g. Front Cardiovasc Med. 2023 Oct 25;10:1309921. doi: 10.3389/fcvm.2023.1309921. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37953759 Free PMC article.
HER2DX genomic test in early-stage HER2-positive breast cancer.
Tolaney SM, Tung N, Wolff AC, DeMichele A, Cejalvo JM, Martínez-Sáez O, Pascual T, Waks AG, Martín M, Ciruelos E, Harbeck N, Carey LA, Cortés J, Curigliano G, Prat A. Tolaney SM, et al. Among authors: curigliano g. ESMO Open. 2024 Dec;9(12):103987. doi: 10.1016/j.esmoop.2024.103987. Epub 2024 Nov 16. ESMO Open. 2024. PMID: 39710442 Free PMC article. Review.
Awareness, Knowledge, and Treatment Patterns of Nonmetastatic Inflammatory Breast Cancer in Low- and Middle-Income Countries: The BRIDGES Study.
Schlam I, Hirko KA, Shveid D, Abuali I, Sewaralthahab S, Nakhils F, Hazra A, Lengyel C, Altuna S, Hussain S, Seid F, Jamil S, Odhiambo A, Leone JP, Metzger O, Abraham J, Soto-Perez-de-Celis E, Chen WY, Block C, Schumer S, Bellon JR, Valenza C, Curigliano G, Tolaney SM, Lynce F, Trapani D. Schlam I, et al. Among authors: curigliano g. JCO Glob Oncol. 2024 Dec;10:e2400307. doi: 10.1200/GO-24-00307. Epub 2024 Dec 20. JCO Glob Oncol. 2024. PMID: 39705637
Methodological issues in radiomics: impact on accuracy of MRI for predicting response to neoadjuvant chemotherapy in breast cancer.
Netti S, D'Ecclesiis O, Corso F, Botta F, Origgi D, Pesapane F, Agazzi GM, Rotili A, Gaeta A, Scalco E, Rizzo G, Jereczek-Fossa BA, Cassano E, Curigliano G, Gandini S, Raimondi S. Netti S, et al. Among authors: curigliano g. Eur Radiol. 2024 Dec 19. doi: 10.1007/s00330-024-11260-y. Online ahead of print. Eur Radiol. 2024. PMID: 39702630
Deep learning algorithm on H&E whole slide images to characterize TP53 alterations frequency and spatial distribution in breast cancer.
Frascarelli C, Venetis K, Marra A, Mane E, Ivanova M, Cursano G, Porta FM, Concardi A, Ceol AGM, Farina A, Criscitiello C, Curigliano G, Guerini-Rocco E, Fusco N. Frascarelli C, et al. Among authors: curigliano g. Comput Struct Biotechnol J. 2024 Nov 26;23:4252-4259. doi: 10.1016/j.csbj.2024.11.037. eCollection 2024 Dec. Comput Struct Biotechnol J. 2024. PMID: 39678362 Free PMC article.
Phase 1/2 Study of the Indoleamine 2,3-Dioxygenase 1 Inhibitor Linrodostat Mesylate Combined With Nivolumab or Nivolumab and Ipilimumab in Advanced Solid Tumors or Hematologic Malignancies.
Luke JJ, Gelmon K, Siu LL, Moreno V, Desai J, Gomez-Roca CA, Carlino MS, Pachynski RK, Cosman R, Chu QS, Damian S, Curigliano G, Tam R, Wang X, Jeyamohan C, Wang L, Zhu L, Santucci-Pereira J, Greenawalt DM, Tabernero J. Luke JJ, et al. Among authors: curigliano g. Clin Cancer Res. 2024 Dec 13. doi: 10.1158/1078-0432.CCR-24-0439. Online ahead of print. Clin Cancer Res. 2024. PMID: 39670852
833 results